Shifang Yang

671 total citations
34 papers, 451 citations indexed

About

Shifang Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shifang Yang has authored 34 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Shifang Yang's work include Cell death mechanisms and regulation (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Antibiotic Use and Resistance (4 papers). Shifang Yang is often cited by papers focused on Cell death mechanisms and regulation (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Antibiotic Use and Resistance (4 papers). Shifang Yang collaborates with scholars based in China, Hong Kong and Australia. Shifang Yang's co-authors include Jungang Xie, Xinglin Gao, Jianping Zhao, Yongjian Xu, Yiyu Deng, Hanyi Xu, Zixing Chen, Xuefu Chen, Ming Gao and Aiping Wang and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Journal of Thoracic Oncology.

In The Last Decade

Shifang Yang

30 papers receiving 440 citations

Peers

Shifang Yang

IMMUN

PRM

ONCOL

Ronghua Xu China

Zhiwei Xu China

Usha Agrawal India

Cong Xie China

Rebecca Collins United States

Xiang‐Qian Luo China

Deng‐Chyang Wu Taiwan

Maria Concetta Volpe Italy

Takahiro Kageyama Japan

Lei Yuan China

Ronghua Xu China

Shifang Yang

203 ×1.0

49 ×0.6

IMMUN

105 ×1.3

PRM

102 ×1.2

81 ×1.4

ONCOL

Citations per year, relative to Shifang Yang Shifang Yang (= 1×) peers Ronghua Xu

Countries citing papers authored by Shifang Yang

Since Specialization

Citations

This map shows the geographic impact of Shifang Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shifang Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shifang Yang more than expected).

Fields of papers citing papers by Shifang Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shifang Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shifang Yang. The network helps show where Shifang Yang may publish in the future.

Co-authorship network of co-authors of Shifang Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shifang Yang. A scholar is included among the top collaborators of Shifang Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shifang Yang. Shifang Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gong, Yanbin, Changki Mo, Hongbo Su, et al.. (2025). AI-driven smartphone screening for acute COPD exacerbations: enhancing health equity in developing regions. npj Digital Medicine. 8(1). 715–715.

Li, Xiying, Chaojie Liu, Manzhi Zhao, et al.. (2025). Point-of-care testing reduces antibiotic prescribing in acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis. International Journal of Infectious Diseases. 155. 107889–107889.

Zhang, Jin, et al.. (2025). EasySpiro: Assessing Lung Function via Arbitrary Exhalations on Commodity Earphones. Rare & Special e-Zone (The Hong Kong University of Science and Technology). 513–528.

Zhang, Jin, et al.. (2024). DeepBreath: Breathing Exercise Assessment with a Depth Camera. Proceedings of the ACM on Interactive Mobile Wearable and Ubiquitous Technologies. 8(3). 1–26. 2 indexed citations

Li, Xiying, Chaojie Liu, Shanquan Chen, et al.. (2024). Global antimicrobial resistance and antibiotic use in COVID-19 patients within health facilities: A systematic review and meta-analysis of aggregated participant data. Journal of Infection. 89(1). 106183–106183. 25 indexed citations

Li, Weibin, et al.. (2023). The association between ambient temperature and antimicrobial resistance of Klebsiella pneumoniae in China: a difference-in-differences analysis. Frontiers in Public Health. 11. 11 indexed citations

Liu, Jia, Tienian Zhu, Jiankun Liu, et al.. (2023). Synergistic antitumor effects of circularly permuted TRAIL with doxorubicin in triple-negative breast cancer. Acta Biochimica et Biophysica Sinica. 55(8). 1247–1256. 4 indexed citations

Zhao, Manzhi, et al.. (2022). Myostatin is involved in skeletal muscle dysfunction in chronic obstructive pulmonary disease via Drp-1 mediated abnormal mitochondrial division. Annals of Translational Medicine. 10(4). 162–162. 11 indexed citations

Li, Siqi, et al.. (2021). Effect of cigarette smoke extract on mitochondrial division in mouse quadriceps femoris cells. Annals of Translational Medicine. 9(22). 1699–1699. 5 indexed citations

10.

Liu, Yuanling, Jianan Chen, Siqi Li, et al.. (2021). Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages. Sleep And Breathing. 26(2). 893–906. 17 indexed citations

11.

Liu, Tao, Jiufeng Sun, Miaoyun Wen, et al.. (2020). Experiences and Lessons of Combating COVID-19 that Chinese Experts Shared with the World. China CDC Weekly. 2(43). 848–850. 1 indexed citations

12.

Gao, Ming, Xuefu Chen, Yiyu Deng, et al.. (2020). A study on infectivity of asymptomatic SARS-CoV-2 carriers. Respiratory Medicine. 169. 106026–106026. 97 indexed citations

13.

Li, Qiong, Li‐Xu Yan, Zhou Zhang, et al.. (2017). ALK and ROS1 Double-Rearranged Lung Squamous Cell Carcinoma Responding to Crizotinib Treatment: A Case Report. Journal of Thoracic Oncology. 12(12). e193–e197. 9 indexed citations

14.

Leng, Yun, Lugui Qiu, Jian Hou, et al.. (2016). Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma. Chinese Journal of Cancer. 35(1). 86–86. 19 indexed citations

15.

Yang, Shifang, Xiaojie Wu, Junling Zhao, et al.. (2014). Interleukin-33/ST2 signaling promotes production of interleukin-6 and interleukin-8 in systemic inflammation in cigarette smoke-induced chronic obstructive pulmonary disease mice. Biochemical and Biophysical Research Communications. 450(1). 110–116. 49 indexed citations

16.

Chen, Wen-Ming, Lugui Qiu, Jian Hou, et al.. (2012). Phase Ib Study of Recombinant Circularly Permuted TRAIL (CPT) in Relapsed or Refractory multiple Myeloma Patients. Blood. 120(21). 1857–1857. 7 indexed citations

17.

Xie, Jungang, Jianping Zhao, Chengfeng Xiao, et al.. (2010). Reduced heat shock protein 70 in airway smooth muscle in patients with chronic obstructive pulmonary disease. Experimental Lung Research. 36(4). 219–226. 13 indexed citations

18.

Xie, Jungang, et al.. (2009). XRCC1 Arg194Trp polymorphism and risk of chronic obstructive pulmonary disease. Journal of Huazhong University of Science and Technology [Medical Sciences]. 29(5). 551–556. 5 indexed citations

19.

Hu, Weihua, Jungang Xie, Jianping Zhao, et al.. (2008). Involvement of Bcl-2 Family in Apoptosis and Signal Pathways Induced by Cigarette Smoke Extract in the Human Airway Smooth Muscle Cells. DNA and Cell Biology. 28(1). 13–22. 25 indexed citations

20.

Tang, Chuanhao, Xiaoqing Liu, Shifang Yang, Bing Zhu, & Hong‐Jun Gao. (2008). [Inhibitory effects of a combination of rmhTRAIL and gemcitabine on human non-small cell lung cancer cell line NCI-H460 cells in vitro and in vivo].. PubMed. 30(11). 808–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact